AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

NewAmsterdam Pharma Company N.V.

$20.06 -$15.14 (-43.01%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$20.76
Day Range
$19.78$20.94
Year Range
$19.13$42.21
Market Cap
2.35B
AVG Volume
1.34M
Trailing/Forward PE
-9.2/-
PEG ratio
-0.4
Dividend Yield
-
Next Earnings Date
2026-11-04
Primary Exchange
NASDAQUS
Revenue (USD) · Q
010M20M30M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NAMS Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q23.7M
26 Q13.04M
25 Q432K
25 Q3348K
25 Q219.14M
25 Q12.98M
24 Q412.77M
24 Q329.11M
24 Q22.28M
24 Q11.4M
Net Income (USD) · Q
-100M-75M-50M-25M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NAMS Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-64.14M
26 Q1-48.44M
25 Q4-74.92M
25 Q3-72M
25 Q2-17.36M
25 Q1-39.53M
24 Q4-92.18M
24 Q3-16.65M
24 Q2-39.01M
24 Q1-93.77M
Operating Income (USD) · Q
-80M-60M-40M-20M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NAMS Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-64.86M
26 Q1-58.42M
25 Q4-65.98M
25 Q3-55.14M
25 Q2-35.63M
25 Q1-68.92M
24 Q4-43.23M
24 Q3-25M
24 Q2-52.58M
24 Q1-55.48M
EBITDA · Q
Cash Flows · Q
EPS · Q
Expenses · Q
Cash & Debt · Q
Debt ratios · Q
Margins · Q
Return on Capital · Q
Shares Outstanding · Q
Dividends (USD) · Q
Employee Count
Book Value Per Share · Q
Total Assets · Q
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: NAMS

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 4 Nov 2026.

NewAmsterdam Pharma Company N.V.
NAMS
Stockpicker

Video analysis: NAMS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: NAMS

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.